C ocaine is a commonly abused (1) stimulant and euphoriant (2) with strong reinforcing effects (3) (4) (5) . The mode of action of cocaine has been the subject of scientific interest for more than a century (2) . The more recent awareness of the existence of a "cocaine abuse epidemic" has added a sociopolitical dimension to research on this drug (6) and has resulted in a more vigorous effort in the search for a specific pharmacological approach to cocaine dependency. To establish a putative treatment algorithm, cocaine's euphorigenic effects on the human brain must be explained.
It has been demonstrated in animals that cocaine exerts its effects by interacting with dopaminergic synapses (7) . Cocaine likely interacts with the dopaminergic system by binding to the dopamine transporter, thus inhibiting dopamine reuptake from the synaptic cleft into the presynaptic terminal (8) . This mechanism leads to an increase of available dopamine. The neural basis of cocaine reinforcement identified in animal models seems to involve an enhancement of dopaminergic neurotransmission in dopamine cells situated in the ventral tegmental area (9, 10) . Although broadly supported by animal studies, the "dopamine hypothesis" of cocaine's actions has not been supported by studies in humans (11) .
It is difficult to compare directly the euphoriant and reinforcing effects of cocaine exhibited in animal models with these effects in humans. Therefore, we set out to correlate possible changes in dopamine concentration with subjective self-ratings of euphoria after an acute Presented in part at the 148th Annual Meeting of the American Psychiatric Association, May 20-25, 1995 
METHOD

Subjects
We studied 11 men (mean age=36 years, SD=5.2, range=28-44) who had been abusing intravenous drugs for more than 10 years. All 11 men had the DSM-III-R diagnosis of cocaine abuse, and all regularly abused cocaine and marijuana. Ten men also abused opiates intermittently. Ten men were African American and one was Caucasian. Subjects were recruited by word of mouth from the East Baltimore community. All of the men were healthy as assessed by a thorough physical examination and basic medical laboratory results, including chest X-ray and performance on a stress ECG. Plasma pseudocholinesterase activity was measured in all of the men to ensure adequate metabolism of cocaine-like agents as an additional safety measure. Written informed consent was obtained according to the guidelines of the Joint Committee on Clinical Investigation of Johns Hopkins Hospital.
Subjects refrained from taking any drugs for at least 48 hours before hospitalization. Twenty-four hours before the beginning of the PET study, the men were admitted to the inpatient Clinical Research Center of Johns Hopkins Hospital, where an observed urine toxicological screen of commonly abused substances was performed to check for compliance with the instructions on drug abstinence. None of the subjects screened positive for any drug of abuse.
PET Studies
On the day of the study, subjects were scanned with a GE4096-plus whole-body PET camera (resolution was 5-6 mm in plane, 6-7 mm z axis). The men were given a mean of 20.6 mCi (SD=10.5) of intravenous [ 11 C]raclopride at baseline and a mean of 19.7 mCi (SD=20.7) of intravenous [ 11 C]raclopride during the drug scan; injected doses were not significantly different (t=1.45). The specific activities between baseline and the drug scans (mean=3347 mCi/mmol, SD= 2963, and mean=2096 mCi/mmol, SD=1832) were also not different (t=1.40). After 0-10 minutes, subjects were injected over a period of approximately 40 seconds with either saline in the placebo scan or 48 mg of cocaine hydrochloride in the drug scan. The cocaine scan always followed the placebo scan by 4-6 hours. Since the time to reach equilibrium is variable among subjects, it was difficult a priori to choose an ideal time for the cocaine injection. Therefore, we systematically varied the time of drug injection: six men received placebo or cocaine 10 minutes after the [ 11 C]raclopride injection, two subjects received placebo or cocaine 5 minutes after, one subject received placebo or cocaine 0 minutes after, and two subjects received placebo or cocaine in a split-dose regimen of 32 mg after 4 minutes and 16 mg after 10 minutes. Throughout the study, the subjects' ECG, blood pressure, and heart rate were monitored. Blood pressure and heart rate were also recorded.
Starting 2 minutes before the injection of cocaine or placebo and every 2 minutes thereafter, a simple visual analog scale questionnaire (16) was administered for the first 20 minutes of the study. Subjects used the fingers of the dominant hand to indicate, on a scale of 0-5, the subjectively perceived strength of the drug effect. This particular procedure was chosen because verbal participation of subjects would result in head movement and lead to difficulties in image analysis.
Subjects wore individualized thermoplastic face masks to standardize positioning in the scanner with the aid of a laser beam. A CT scan determined which angle of alignment was parallel to the orbitomeatal line. A radial arterial line was placed to obtain blood samples for input sampling. Scans were acquired at 50 time points over a period of 90 minutes. Acquisition duration varied from 15 to 240 The two slices on which the basal ganglia were best visible were selected from a total of 15 axial slices and averaged. The resulting image was filtered by using a Hanning filter, and three regions of interest were placed interactively on each left and right putamen by a rater who was blind to the experimental condition. The activities of the six regions of interest were averaged to obtain activity in the putamen. The figure represents a 4-minute sampling period 18 minutes after injection of [ 11 C]raclopride in one subject.
seconds; the first eight scans were acquired over 15 seconds, the next 16 over 30 seconds, the next eight over 60 seconds, and the remaining 18 over 240 seconds.
Image Analysis
Time-activity curves for putamen and cerebellum were derived in both the placebo and the drug scans. Fifteen axial slices of 6.5-mm full width at half maximum were acquired. Images were reconstructed in a 128×128 matrix with a pixel size of 2 mm. The two scan slices where the basal ganglia were best visible were averaged, and the resulting image was low-pass filtered by using a 6-mm cutoff Hanning filter to reduce statistical noise. The same procedure was applied to two slices where the cerebellum was best visible. To assess a time-activity curve of total binding to receptors in the basal ganglia, three 4×4-pixel-wide regions of interest were subsequently placed by a rater, blind to the experimental condition, for each left and right putamen on every one of the 50 averaged slices (figure 1) of the dynamic acquisition. A 6×8-pixel-wide region of interest was placed in each left and right cerebellar slice to assess nonspecific binding. Specific binding was calculated by subtracting the cerebellar activity from the activity in the putamen, both corrected for the amount of injected radioactivity.
Statistical Analysis
We used the Wilcoxon signed rank test to compare the scores of the subjective measures for cocaine effects because the distribution of values was not normal. We used paired t tests to compare blood pressure and heart rate as well as activity measures 7.5 minutes after injection of cocaine or placebo, respectively. For both conditions we used a paired t statistic to calculate and compare the total area under the time-activity curve (corrected for injected activity) as assessed with the Riemann method.
RESULTS
All subjects tolerated the experimental procedures well. According to their ratings on the visual analog scale (16) , all of the men reported various degrees of greater subjective euphoriant effects after cocaine than after placeo administration. Peak values for self-reported "rush" and "high" were reached 2 minutes after cocaine injection. All subjects reported increases over baseline after cocaine administration: the mean increase in ratings of "rush" was 3.4 (SD=1.5) (Wilcoxon Z= 2.8, N=11, p<0.005); the mean increase in ratings of "high" was 2.8 (SD=1.7) (Wilcoxon Z=2.8, N=22, p<0.005).
Blood pressure and heart rate also differed between baseline conditions and 7.5 minutes after cocaine injection: the mean change in systolic pressure was 14.5 mm Hg (SD=9.54) (one-tailed t=5.1, df=10, p<0.001); the mean change in diastolic pressure was 8.2 mm Hg (SD=8.1) (one-tailed t=3.4, df=10, p<0.01); the mean change in heart rate was 29.6 bpm (SD=24.3) (onetailed t=4.0, df=10, p<0.01). There was a significant correlation between the self-reported values for "rush" and "high" 2 minutes after the first cocaine injection and the degree of change in systolic (r=0.64 for "rush and r=0.68 for "high") and diastolic (r=0.69 for "rush" and r=0.66 for "high") blood pressure from 1 minute before cocaine injection to 7 minutes after.
As shown in figure 2 , eight of the 11 men showed lower activity in the putamen during the cocaine condition than in the placebo condition. Previous data (17) suggested that maximal physiological cocaine effects are reached 8 minutes after injection. Therefore, we calculated a paired means comparison for the difference in specific binding 7.5 minutes after injection of cocaine. This analysis revealed significant differences (t=4.0, df= 10, p<0.01). The total mean area under the time-activity curve (corrected for the amount of injected dose of radioactivity) as assessed with the Riemann method was 251.0 (SD=45.5) in the placebo condition and 224.1 (SD=39.1) in the cocaine condition. A paired t test revealed a significant difference between the two conditions (t=6.7, df=10, p<0.0001).
DISCUSSION
Converging evidence from preclinical research generated over the last 25 years has convincingly established the pivotal role of dopamine in stimulant reward (18) (19) (20) (21) (22) . The neuroanatomical correlates of these stimulant euphorigenic mechanisms in the dopaminergic reward regions of the human brain is very important because it might provide new avenues for potential treatments (23) . Despite this, we are aware of only one study that tried to correlate cocaineinduced euphoria with changes in dopamine concentration in human subjects (24) .
Our study of 11 men demonstrated significant displacement of a radiolabeled D 2 receptor antagonist in response to intravenous administration of 48 mg of cocaine hydrochloride. This dose, similar to typical "street" doses, exerted clear subjective pharmacological effects that are in agreement with those we reported previously (16) . In view of the available in vitro and in vivo animal data, this effect is most likely associated with an increase in intrasynaptic dopamine levels, produced by a blockade of dopamine reuptake due to the binding of cocaine to the dopamine transporter. Our results also demonstrate that increases in dopamine in the putamen, at least as measured by [ 11 C]raclopride binding, are not necessarily correlated with cocaine "rush" and "high." Since it is dopamine release in the nucleus accumbens (25) and possibly the ventral pallidum (26), but not the striatum, that seems to be responsible for the euphoric effects of cocaine and amphetamine, the assumption must be made that the changes in dopamine levels in the putamen observed in the current study do not reflect similar changes in the accumbens.
A weakness of this study is the use of varying time intervals between [ 11 C]raclopride and cocaine administration, which mars the comparability of the results. This procedure was chosen because we were not able to identify an ideal time for the cocaine injection a priori.
Cocaine acts as a potent vasoconstrictor and is associated clinically with both cardiovascular problems (27) and stroke (28) . One might argue that the effects of cocaine demonstrated in this study are attributable to decreased cerebral blood flow and resulting slower delivery of [ 11 C]raclopride to D 2 basal ganglia receptors. We tried to defend against this potential criticism by administering cocaine to most subjects 10 minutes after [ 11 C]raclopride administration. The similar time-activity curves in the cerebellum in both placebo and drug conditions additionally suggest that blood flow differences did not contribute to our findings.
Continued use of cocaine reportedly can cause both tolerance and sensitization, suggesting adaptive changes in brain neurochemistry (29) . Our observation of a rather large standard deviation in the maximal activities in the putamen is consistent with such effects. Furthermore, the degree of subjective euphoriant drug effects, as assessed with a visual analog scale, correlated negatively with age, analogous to a report by Volkow et al. (15) . The subject who had the lowest activity (the second graph from the left in the top row of figure 2) reported the longest history of cocaine abuse (22 years). This observation is consistent with previous findings (30) suggesting that chronic cocaine abuse may affect dopaminergic receptors.
In summary, we believe that our data offer support for the application of the dopamine hypothesis of cocaine's actions (developed with animal data) to human subjects. Furthermore, our data confirm that it is possible, by using functional radioligand imaging techniques, to demonstrate acute central actions of pharmacological agents of abuse on human dopaminergic neurotransmitter systems in vivo.
